ITOCHealthcare · Medical DevicesTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 25 of 100 as at 12 Sept 2026 — in the lower half.
Consensus tells you what everyone already believes. The model scores iTonic Holdings Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (96): Smaller than most of the companies we track.
Value (13): The shares cost a lot relative to the profits and assets behind them.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on ITOC, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ITOC appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 11 Sept 2026, iTonic Holdings Ltd. returned −67.4% against +17.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 11% of US stocks
Cheaper than 77% of US stocks
Cheaper than 66% of US stocks
Higher than 92% of US stocks
Higher than 7% of US stocks
Higher than 97% of US stocks
Higher than 17% of US stocks
Higher than 10% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
iTonic Holdings Ltd. has a market value of $7.5M and an enterprise value of $4.4M.
iTonic Holdings Ltd. employs 7 people.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own iTonic Holdings Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Bronstein, Gewirtz & Grossman LLC, an investor-rights law firm, announced that a class action lawsuit has been filed against iTonic Holdings Ltd., formerly known as Pheton Holdings Ltd.
Why it matters — ITOC watchers would care because the company is now subject to a class action lawsuit announced by a national investor-rights law firm.
Levi & Korsinsky has reminded shareholders of a September 29, 2026 lead plaintiff deadline in a securities class action lawsuit against iTonic Holdings Ltd (formerly Pheton Holdings Ltd). The suit alleges the company failed to disclose the documented microcap manipulation history of the gatekeepers who took it public.
Why it matters — A shareholder class action and upcoming lead plaintiff deadline signal legal and disclosure concerns that ITOC watchers would want to monitor.
Bronstein, Gewirtz & Grossman LLC, a national investor-rights law firm, announced that a class action lawsuit has been filed against iTonic Holdings Ltd. (formerly Pheton Holdings Ltd.). The firm is publicizing the lawsuit to potential investors.
Why it matters — A class action lawsuit has been filed against iTonic Holdings, which could expose the company to legal and financial liabilities and raise investor concerns.
Bronstein, Gewirtz & Grossman LLC announced that a class action lawsuit has been filed against iTonic Holdings Ltd. (formerly Pheton Holdings Ltd.). The investor-rights law firm made the announcement in New York on September 4, 2026.
Why it matters — The filing of a class action lawsuit against the company signals potential legal and reputational risk that iTonic Holdings investors may wish to monitor.
Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announced that a class action lawsuit has been filed against iTonic Holdings Ltd., formerly known as Pheton Holdings Ltd. The announcement was made on September 1, 2026.
Why it matters — A class action lawsuit has been filed against iTonic Holdings, which is a legal development that shareholders and investors tracking the company would want to be aware of.
As at 12 Sept 2026, iTonic Holdings Ltd. ranks 25 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (96 of 100).
No analyst covering iTonic Holdings Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ITOC are extrapolating price history, which says nothing about the business.
iTonic Holdings Ltd. returned -67.4% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
iTonic Holdings Ltd. is a healthcare solutions company focused on brachytherapy, a targeted form of radiation therapy used in cancer treatment.
The most recent item we track (GlobeNewsWire, 11 Sept 2026): "Bronstein, Gewirtz & Grossman LLC Urges iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd.". Bronstein, Gewirtz & Grossman LLC, an investor-rights law firm, announced that a class action lawsuit has been filed against iTonic Holdings Ltd., formerly known as Pheton Holdings Ltd.
iTonic Holdings Ltd. is a healthcare solutions company focused on brachytherapy, a targeted form of radiation therapy used in cancer treatment. Through its operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., the company develops and commercializes treatment planning software and related devices designed to support precise radioactive source placement and dose planning. Its core product, FTTPS, is used to help clinicians define target volumes, prescribe doses, and protect nearby organs during treatment. The company also offers medical auxiliary supplies, including seed implant needles, computer workstations, and patient positioning devices, which support clinical workflows in brachytherapy procedures. Headquartered in Beijing, China, iTonic Holdings Ltd. serves the medical technology market with solutions aimed at improving planning accuracy and treatment delivery in oncology care.
CEO Mr. Jianfei Zhang · 7 employees · China · https://www.ftzy.com.cn
